Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Grant or award Director acquired 25,797 shares (grant or award)
  2. 4 Open-market buy CEO & President bought 20,000 shares at $0.21 ($4,240)
  3. 4 Grant or award Director acquired 27,412 shares (grant or award)
  4. 4 Grant or award Director acquired 27,412 shares (grant or award)
  5. 4 Grant or award Director acquired 8,768 shares (grant or award)
  6. 4 Grant or award Director acquired 26,305 shares (grant or award)
  7. 4 Grant or award Director acquired 26,305 shares (grant or award)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market sale Director sold 4,580 shares at $0.19 ($884)
  10. 4 Open-market buy CEO & President bought 22,727 shares at $0.21 ($4,682)
  11. 4 Grant or award Director acquired 24,452 shares (grant or award)
  12. 4 Grant or award Director acquired 24,452 shares (grant or award)
  13. 4 Grant or award Director acquired 24,452 shares (grant or award)
  14. 4 Open-market buy Director bought 11,112 shares at $0.21 ($2,356)
  15. 4 Grant or award Director acquired 22,645 shares (grant or award)
  16. 4 Grant or award Director acquired 22,645 shares (grant or award)
  17. 4 Grant or award Director acquired 22,645 shares (grant or award)
  18. 4 Open-market buy CEO & President bought 85,000 shares at $0.20 ($16,915)
  19. 4 Open-market buy Director bought 81,953 shares at $0.19 ($15,817)
  20. 4 Open-market buy CEO & President bought 60,110 shares at $0.18 ($11,000)

Page 3 of 31 · 614 filings